Skip to content
Recall Observatory FDA recall evidence

Drug product

Terazosin Hydrochloride Capsules, 2 mg, packaged in a) 100-count bottles (NDC 0093-4337-01); and b) 1000-count bottles (NDC 0093-4337-10), Rx only, Manufactured in India By: Intas Pharmaceuticals Ltd., Ahmedabad, Gujarat, India - 382 210; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960.

D-193-2013

January 23, 2013

Class II

Product summary

Firm
Teva Pharmaceuticals USA, Inc.
Event
Event 64233
Status
Terminated
Classification
Class II
Quantity
3,913 bottles
Official record key
drug-enforcement:D-193-2013

Official wording

Reason: Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.

Code information: Lot # N03029, Exp 03/14

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets